Builders FirstSource
BLDR
克罗格
KR
礼来
LLY
4
美国史丹利公司
SWK
5
默沙东
MRK
美股市场个股详情
ADVM Adverum Biotechnologies
- 4.7800
- +0.2900+6.46%
收盘价 01/27 16:00 (美东)
- 4.7800
- 0.00000.00%
盘后 16:09 (美东)
9943.58万总市值-0.80市盈率TTM
4.8400最高价4.3700最低价35.06万股成交量4.3700今开4.4900昨收166.10万成交额3.03%换手率亏损市盈率(静)2080.25万总股本29.700052周最高0.69市净率5529.32万流通值4.010052周最低--股息TTM1156.76万流通股624.8000历史最高--股息率TTM10.47%振幅4.0100历史最低4.7370平均价1股每手
Adverum Biotechnologies所有资讯
Adverum Biotechnologies | S-8：员工福利计划证券登记
Adverum Biotechnologies | SCHEDULE 13G：其他
Adverum Biotechnologies | 8-K：重大事件
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Vivo Opportunity Fund Holdings, L.P.(1.1%),Vivo Opportunity, LLC(1.1%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Logos Global Management LP(2.0%),Logos Global Management GP LLC(2.0%)等
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(0%),Commodore Capital Master LP(0%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(1.128%),Abigail P. Johnson(1.128%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | SC 13G/A：超过5%持股股东披露文件(修正)-Morgan Stanley(0.4%),Morgan Stanley Capital Services LLC(0.1%)
Adverum Biotechnologies | 10-Q：2024财年三季报
Adverum Biotechnologies | 8-K：Adverum Biotechnologies公布2024年第三季度财务业绩，提供公司要点并更新预期里程碑
Adverum Biotechnologies | SCHEDULE 13G：其他
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-Augustus Stern, MD(5.37%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-Principia Wealth Advisory, LLC, EIN: 27-1545452(5.07%)
Adverum Biotechnologies | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | 10-Q：2024财年二季报
Adverum Biotechnologies | 8-K：Adverum Biotechnologies公布2024年第二季度财务业绩并提供计划和公司摘要
Adverum Biotechnologies | 4：持股变动声明-高管 Soparkar Peter
Adverum Biotechnologies | 4：持股变动声明-高管 Seyedkazemi Setareh
Adverum Biotechnologies | 4：持股变动声明-高管 Rubinstein Linda M